N-Methyl-N-(pyrrolidin-3-yl)acetamide hydrochloride
98%
- Product Code: 53234
CAS:
1624261-23-9
| Molecular Weight: | 178.66 g./mol | Molecular Formula: | C₇H₁₅ClN₂O |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | room temperature |
Product Description:
This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of novel drug candidates. It serves as a key intermediate in the production of compounds targeting central nervous system disorders, such as cognitive impairments and neurodegenerative diseases. Its structural features make it valuable for designing molecules with potential therapeutic effects on neurological pathways. Additionally, it is explored in the development of receptor modulators, particularly those interacting with neurotransmitter systems, to address conditions like anxiety, depression, and schizophrenia. Its application extends to preclinical studies, where it aids in understanding the pharmacokinetics and pharmacodynamics of new drug entities.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | $94.19 |
+
-
|
N-Methyl-N-(pyrrolidin-3-yl)acetamide hydrochloride
This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of novel drug candidates. It serves as a key intermediate in the production of compounds targeting central nervous system disorders, such as cognitive impairments and neurodegenerative diseases. Its structural features make it valuable for designing molecules with potential therapeutic effects on neurological pathways. Additionally, it is explored in the development of receptor modulators, particularly those interacting with neurotransmitter systems, to address conditions like anxiety, depression, and schizophrenia. Its application extends to preclinical studies, where it aids in understanding the pharmacokinetics and pharmacodynamics of new drug entities.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :